drugset / Trial / NCT07519577
A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-2）
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, single-arm, multicenter, extension study to evaluate the safety and efficacy of CM512 in patients With Chronic Rhinosinusitis with Nasal Polyposis
Timeline
- Start
- 2026-05-31
- Primary completion
- 2028-05-31
- Completion
- 2028-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CM512 | Unknown | — | Subcutaneous |